HDAC9 and Alzheimer disease: In a multitargeted approach to treat AD, these two inhibitors were attached using a range of linkers to an o-aminoanilide (or thiophene equivalent) ZBG to synthesise a library of dual PDE5/HDAC inhibitors [109].